NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,022 Cr | ₹973 Cr | ₹891 Cr | ₹1,004 Cr | ₹1,187 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹973 Cr |
| Mar2023 | ₹891 Cr |
| Mar2022 | ₹1,004 Cr |
| Mar2021 | ₹1,187 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 5.01 | |
| Mar2024 | ₹973 Cr | 9.19 | |
| Mar2023 | ₹891 Cr | -11.25 | |
| Mar2022 | ₹1,004 Cr | -15.46 | |
| Mar2021 | ₹1,187 Cr | - | |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹262.1 Cr | -0.9% | -13.9% | -64.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.9% |
-13.9% |
-64.7% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses